5 research outputs found

    Effect of ART and derivatives on Huh 5-2 HCV replicon replication.

    No full text
    <p>∶ 50% effective concentration, CC50∶ 50% cytostatic concentration. Data obtained from the measurement of the firefly luciferase activity, and are mean values ± SD for four independent experiments (expressed in µM).<sup></sup> EC50</p><p>µM, Hemin inhibits HCV replicon replication by 30%.<sup></sup> Values between brackets indicate fold-change. At 5 </p

    Structure-Based Discovery of Pyrazolobenzothiazine Derivatives As Inhibitors of Hepatitis C Virus Replication

    No full text
    The NS5B RNA-dependent RNA polymerase is an attractive target for the development of novel and selective inhibitors of hepatitis C virus replication. To identify novel structural hits as anti-HCV agents, we performed structure-based virtual screening of our in-house library followed by rational drug design, organic synthesis, and biological testing. These studies led to the identification of pyrazolobenzothiazine scaffold as a suitable template for obtaining novel anti-HCV agents targeting the NS5B polymerase. The best compound of this series was the <i>meta</i>-fluoro-<i>N</i>-1-phenyl pyrazolobenzothiazine derivative <b>4a</b>, which exhibited an EC<sub>50</sub> = 3.6 μM, EC<sub>90</sub> = 25.6 μM, and CC<sub>50</sub> > 180 μM in the Huh 9–13 replicon system, thus providing a good starting point for further hit evolution
    corecore